title: Antibody therapeutics - the evolving patent landscape.
abstract: The antibody patent landscape has evolved dramatically over the past 30 years, particularly in areas of technology relating to antibody modification to reduce immunogenicity in humans or improve antibody function. In some cases antibody techniques that were developed in the 1980s are still the subject of patent protection in the United States or Canada.
authors.affiliation: FB Rice, Level 23, 200 Queen Street, Victoria 3000, Australia. jpetering@fbrice.com.au
authors.forename: Jenny
authors.initials: J
authors.lastname: Petering
authors.forename: Patrick
authors.initials: P
authors.lastname: McManamny
authors.forename: Jane
authors.initials: J
authors.lastname: Honeyman
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007158:Immunologic Techniques; D010330:Patents as Topic
chemical_list: D000906:Antibodies